Holen Sie sich die Stockscreener-App
0.40
5.17%
-0.0218
Handel nachbörslich:
.40
Schlusskurs vom Vortag:
$0.4218
Offen:
$0.415
24-Stunden-Volumen:
30.37M
Relative Volume:
0.24
Marktkapitalisierung:
$73.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.91M
KGV:
-0.2685
EPS:
-1.49
Netto-Cashflow:
-
1W Leistung:
+15.94%
1M Leistung:
+81.57%
6M Leistung:
-77.74%
1J Leistung:
-79.27%
1-Tages-Spanne:
$0.40
$0.422
1-Wochen-Bereich:
$0.3613
$0.571
52-Wochen-Spanne:
$0.08
$3.1199
Incannex Healthcare Inc Stock (IXHL) Company Profile
Firmenname
Incannex Healthcare Inc
Sektor
Telefon
61 409 840 786
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Vergleichen Sie IXHL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.40 | 39.52M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.96B | 957.25M | 5.31B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.26B | 1.98B | 0 | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten
Promising Cannabis Stocks To Add to Your WatchlistAugust 13th - MarketBeat
What makes Incannex Healthcare Inc. stock price move sharplyBig Earnings Beat Candidates - thegnnews.com
AI Tools Suggest Incannex Healthcare Inc. May Outperform This WeekReal Profit Trade Plan Suggestions Shared Widely - beatles.ru
What are the short-term price targets set by analysts covering Incannex Healthcare? - AInvest
Incannex Shares Surge Following Promising Sleep Apnea Trial Data - MSN
Incannex announces patient-reported outcomes, efficacy data for IXHL-42X - TipRanks
Incannex Healthcare Reports Positive Phase 2 Trial Results - TipRanks
Incannex stock surges after positive sleep apnea trial results By Investing.com - Investing.com Nigeria
Incannex reports positive patient outcomes in OSA treatment trial By Investing.com - Investing.com Nigeria
Incannex reports positive patient outcomes in OSA treatment trial - Investing.com
Revolutionary Sleep Apnea Drug Shows 83% Improvement in Phase 2 Trial, Patients Report Life-Changing Benefits - Stock Titan
Incannex Healthcare's 58% Surge: A Volatility Catalyst or Fleeting Flare? - AInvest
Incannex Healthcare Soars 14.49% on Warrant Cancellation, Clinical Board Expansion - AInvest
Price Action Confirms Reversal in Incannex Healthcare Inc. TrendROI Driven Equity Selection With Safety Emphasized - beatles.ru
What are Incannex Healthcare Inc. company’s key revenue driversInvest smarter with advanced market data - Jammu Links News
Why is Incannex Healthcare Inc. stock attracting strong analyst attentionMaximize your investment portfolio’s performance - Jammu Links News
Does Incannex Healthcare Inc. stock perform well during market downturnsOutstanding growth strategies - Jammu Links News
What institutional investors are buying Incannex Healthcare Inc. stockCapitalize on emerging growth stocks - Jammu Links News
Is Incannex Healthcare Inc. a good long term investmentGet professional advice for portfolio optimization - Jammu Links News
What are the latest earnings results for Incannex Healthcare Inc.Exceptional earning trajectories - Jammu Links News
Is Incannex Healthcare Inc. a growth stock or a value stockUnlock powerful trading signals and alerts - Jammu Links News
When is Incannex Healthcare Inc. stock expected to show significant growthHigh-octane investment opportunities await - Jammu Links News
Incannex Healthcare Confirms Robust Cash Position and Limited ATM Usage - AInvest
How volatile is Incannex Healthcare Inc. stock compared to the marketMarket Forecast Alerts For Smart Trading - jammulinksnews.com
How does Incannex Healthcare Inc. generate profit in a changing economySmart Portfolio Outlook For Consistent Profits - Jammu Links News
What catalysts could drive Incannex Healthcare Inc. stock higher in 2025Stock Strategy Trend Scanner To Watch Now - Jammu Links News
Why Did Incannex Healthcare Plunge 28.03% Despite Positive Trial Results? - AInvest
Incannex has no plans, requirement to fully utilized ATM in near term - TipRanks
IXHL.O Plummets 29% Intraday: A Deep-Dive Into What’s Driving the Sudden Drop - AInvest
Incannex Healthcare shares drop 26.93% intraday after profit-taking and ATM offering expansion. - AInvest
Is Incannex Healthcare Inc. stock entering bullish territoryChart Driven High Reward Trading Setup Presented - metal.it
3 Penny Stocks to Watch Now, 7/29/25 - TipRanks
Incannex Healthcare Highlights Strong Cash Position and Strategy - TipRanks
Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term - The Manila Times
Incannex Reveals $50M Cash Strength and Breakthrough Phase 2 Results: What This Means for Shareholders - Stock Titan
3 Penny Stocks to Watch: Incannex Healthcare, XBP Europe Holdings, and AEye Inc. - AInvest
Top Penny Stocks To Follow NowJuly 26th - MarketBeat
Promising Penny Stocks To Add to Your WatchlistJuly 27th - MarketBeat
IXHL Shares Plunge 17.76% on Record 428.65% Volume Spike as 283rd-Busiest Stock Sparks Market Doubts Amid Promising OSA Trial Data - AInvest
Incannex drops despite mid-stage trial win for lead asset in sleep apnoea - MSN
Incannex stock drops despite trial win for lead asset (IXHL) - Seeking Alpha
Incannex Shares Climb 10% After Sleep Apnea Drug Shows Strong Phase 2 Results - MSN
Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial - Benzinga
Incannex reports positive Phase 2 results for OSA drug candidate By Investing.com - Investing.com South Africa
Incannex stock soars after positive Phase 2 results for sleep apnea drug By Investing.com - Investing.com Nigeria
Incannex stock soars after positive Phase 2 results for sleep apnea drug - Investing.com Nigeria
Incannex Reports Positive Phase 2 Trial Results - TipRanks
Incannex reports positive Phase 2 results for OSA drug candidate - Investing.com
Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X - The Manila Times
IXHLIncannex Healthcare Ltd Latest Stock News & Market Updates - Stock Titan
Incannex Healthcare shares fall 10.28% intraday despite positive topline results from RePOSA Phase 2 clinical trial. - AInvest
Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):